Comorbid patient with non-alcoholic fatty liver disease

Autor:	Elena N. Shirokova
Rok vydání:	2020
Předmět:	medicine.medical_specialty business.industry Internal medicine Fatty liver medicine nutritional and metabolic diseases General Materials Science Non alcoholic Disease business medicine.disease Gastroenterology
Zdroj:	Remedium Journal about the Russian market of medicines and medical equipment. :32-37
ISSN:	1561-5936
DOI:	10.21518/1561-5936-2020-10-32-37
Popis:	The article reviews the evidence for an association between non-alcoholic fatty liver disease (NAFLD) and multiple cardiometabolic disorders, including ischemic stroke, insulin resistance, arterial hypertension, dyslipidemia, chronic kidney disease and cardiac arrhythmias and outlines the mechanisms that underpin this relationship. The role of ursodeoxycholic acid, a drug with pleiotropic properties, in the treatment of NAFLD has been shown.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b1557ec7ad3b485bf7eceb188f1130e4 https://doi.org/10.21518/1561-5936-2020-10-32-37 Zobrazit plný text záznamu